Ancef and Sinus tachycardia - a phase IV clinical study of FDA data

Summary:

Sinus tachycardia is reported as a side effect among people who take Ancef (cefazolin sodium), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Vicodin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Sinus tachycardia when taking Ancef. It is created by eHealthMe based on reports of 3,257 people who have side effects when taking Ancef from the FDA, and is updated regularly.

What is Ancef?

Ancef has active ingredients of cefazolin sodium. eHealthMe is studying from 3,292 Ancef users. Check the latest studies of Ancef.

What is Sinus tachycardia?

Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node) is found to be associated with 1,266 drugs and 1,412 conditions by eHealthMe. Check the latest studies of Sinus tachycardia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

3,257 people reported to have side effects when taking Ancef.
Among them, 42 people (1.29%) have Sinus tachycardia.

Among these 42 people:

How long have people been on Ancef when they have Sinus tachycardia? *

What is the gender of people who have Sinus tachycardia when taking Ancef? *

female: 60.98 %
male: 39.02 %

What is the age of people who have Sinus tachycardia when taking Ancef? *

What are other drugs people take besides Ancef? *

What are other side effects people have besides Sinus tachycardia? *

Pain: 22 people, 52.38%
Weight Decreased: 17 people, 40.48%
Pleural Effusion (water on the lungs): 17 people, 40.48%
Acute Kidney Failure: 17 people, 40.48%
Urinary Tract Infection: 17 people, 40.48%
Anaemia (lack of blood): 17 people, 40.48%
Chest Pain: 17 people, 40.48%
Confusional State: 16 people, 38.10%
Gastric Ulcer (stomach ulcer): 16 people, 38.10%
Nausea (feeling of having an urge to vomit): 16 people, 38.10%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 14 people, 33.33%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 13 people, 30.95%
Breast Cancer: 10 people, 23.81%
Pain: 6 people, 14.29%
High Blood Pressure: 4 people, 9.52%
Vaginal Bleeding: 2 people, 4.76%
Diabetes: 2 people, 4.76%
Menopause (end of monthly cycles in women): 2 people, 4.76%
Abdominal Pain Upper: 1 person, 2.38%
Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Ancef and have Sinus tachycardia?

- Check whether Sinus tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ancef:

Ancef (3,292 reports)

Browse all side effects of Ancef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus tachycardia:

Sinus tachycardia (1,266 drugs)

Browse all the conditions that are associated with Sinus tachycardia:

Sinus tachycardia (1,412 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Ancef) and Ancef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.